CHRD plans sale of 2,200 common shares

CHRD submitted a notice of proposed sale of 2,200 shares of common stock through J.P.

Rhea-AI Filing Summary

CHRD submitted a notice of proposed sale of 2,200 shares of common stock through J.P. Morgan Securities LLC, to be sold on or after 08/10/2026 on the NASDAQ. The shares listed have an aggregate market value of $288,970, compared to 54,697,872 CHRD common shares outstanding.

The filing also lists prior issuer-related compensation stock transactions of 815 shares on 08/01/2023 and 1,385 shares on 04/26/2024, both described as compensation from the issuer.

Key Figures

Planned shares to be sold: 2,200 shares Aggregate market value of planned sale: $288,970 Shares outstanding: 54,697,872 shares +3 more

6 metrics

Planned shares to be sold 2,200 shares Common stock proposed for sale through J.P. Morgan Securities LLC

Aggregate market value of planned sale $288,970 Reported value of 2,200 CHRD common shares to be sold

Shares outstanding 54,697,872 shares Total CHRD common shares outstanding referenced in the filing

Planned sale date 08/10/2026 Date listed for proposed NASDAQ sale of common stock

Compensation shares (08/01/2023) 815 shares Common stock received as compensation from issuer on 08/01/2023

Compensation shares (04/26/2024) 1,385 shares Common stock received as compensation from issuer on 04/26/2024

Key Terms

Form 144, Securities To Be Sold, aggregate market value, compensation, +1 more

5 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"NASDAQ 144: Securities To Be Sold"

aggregate market value financial

"Common Stock | J.P. Morgan Securities LLC ... | 2200 | 288970 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

compensation financial

"Common Stock | 08/01/2023 | Compensation | Issuer |"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CHRD's latest Form 144 filing disclose?

CHRD’s Form 144 discloses a proposed sale of 2,200 shares of common stock, with an aggregate market value of $288,970, to be executed through J.P. Morgan Securities LLC on or after 08/10/2026 on the NASDAQ market.

How many CHRD shares are planned to be sold under this Form 144?

The filing indicates a planned sale of 2,200 CHRD common shares. These shares are listed with an aggregate market value of $288,970, and the sale is expected to occur through J.P. Morgan Securities LLC on or after 08/10/2026.

What is the aggregate market value of the CHRD stock in this Form 144?

The proposed 2,200 CHRD shares to be sold have an aggregate market value of $288,970. This value is reported alongside total common shares outstanding of 54,697,872, providing context for the relative size of the planned sale.

How many CHRD shares are outstanding according to the Form 144?

The Form 144 reports 54,697,872 CHRD common shares outstanding. This figure serves as a reference point against which the planned sale of 2,200 shares can be compared as a relatively small portion of the total equity base.

What prior CHRD stock transactions are referenced in the Form 144?

The filing references issuer compensation transactions of 815 shares dated 08/01/2023 and 1,385 shares dated 04/26/2024. Both are described as common stock received as compensation from the issuer, not market sales by the holder.

Which broker will handle the planned CHRD share sale?

The proposed sale of 2,200 CHRD common shares will be handled by J.P. Morgan Securities LLC. The broker’s address is listed as 270 Park Avenue, 10th Floor, New York, NY 10017, and the shares are expected to trade on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 05:25 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001805570
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chord Energy Corporation
SEC File Number	001-34776
Address of Issuer	1001 FANNIN STREET, Suite 1500 Houston TEXAS 77002
Phone	281-404-9500
Name of Person for Whose Account the Securities are To Be Sold	Samantha McKinney
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	2200	288970	54697872	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/01/2023	Compensation	Issuer			815	08/01/2023	Compensation
Common Stock	04/26/2024	Compensation	Issuer			1385	04/26/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Samantha McKinney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)